111 related articles for article (PubMed ID: 37644015)
41. Prognostic significance of FOXM1 in oral squamous cell carcinoma patients treated by docetaxel-containing regimens.
Harada K; Ferdous T; Minami H; Mishima K
Mol Clin Oncol; 2019 Jan; 10(1):29-36. PubMed ID: 30655974
[TBL] [Abstract][Full Text] [Related]
42. KIF4A is a promising prognostic marker and correlates with immune infiltration in clear cell renal cell carcinoma.
Li C; Chen J; Su Z
Transl Cancer Res; 2020 Nov; 9(11):7165-7173. PubMed ID: 35117320
[TBL] [Abstract][Full Text] [Related]
43. A pan-cancer analysis of the oncogenic role of ERCC6L.
Lu Z; Fei L; Hou G
BMC Cancer; 2022 Dec; 22(1):1347. PubMed ID: 36550435
[TBL] [Abstract][Full Text] [Related]
44. Enhanced expression of KIF4A in osteosarcoma predicts a poor prognosis and facilitates tumor growth by activation of the MAPK pathway.
Zhu D; Xu X; Zhang M; Wang T
Exp Ther Med; 2021 Nov; 22(5):1339. PubMed ID: 34630693
[TBL] [Abstract][Full Text] [Related]
45. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.
Gemenetzidis E; Bose A; Riaz AM; Chaplin T; Young BD; Ali M; Sugden D; Thurlow JK; Cheong SC; Teo SH; Wan H; Waseem A; Parkinson EK; Fortune F; Teh MT
PLoS One; 2009; 4(3):e4849. PubMed ID: 19287496
[TBL] [Abstract][Full Text] [Related]
46. RAD52 and ERCC6L/PICH have a compensatory relationship for genome stability in mitosis.
Osia B; Merkell A; Lopezcolorado FW; Ping X; Stark JM
bioRxiv; 2023 Aug; ():. PubMed ID: 37662271
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathological and prognostic significance of FOXM1 expression in esophageal squamous cell carcinoma.
Takata A; Takiguchi S; Okada K; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Mori M; Doki Y
Anticancer Res; 2014 May; 34(5):2427-32. PubMed ID: 24778055
[TBL] [Abstract][Full Text] [Related]
48. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
[TBL] [Abstract][Full Text] [Related]
49. shRNA knockdown of DNA helicase ERCC6L expression inhibits human breast cancer growth.
Liu J; Sun J; Zhang Q; Zeng Z
Mol Med Rep; 2018 Sep; 18(3):3490-3496. PubMed ID: 30066865
[TBL] [Abstract][Full Text] [Related]
50. USP39 interacts with SIRT7 to promote cervical squamous cell carcinoma by modulating autophagy and oxidative stress via FOXM1.
Yu J; Yuan S; Song J; Yu S
J Transl Med; 2023 Nov; 21(1):807. PubMed ID: 37957720
[TBL] [Abstract][Full Text] [Related]
51. Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity.
Chen CH; Chien CY; Huang CC; Hwang CF; Chuang HC; Fang FM; Huang HY; Chen CM; Liu HL; Huang CY
Oncogene; 2009 Jul; 28(30):2723-37. PubMed ID: 19525975
[TBL] [Abstract][Full Text] [Related]
52. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
[TBL] [Abstract][Full Text] [Related]
53. Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells.
Zhang C; Wang M; Ying Y; Meng F; Gao H; Zeng S; Zhu Y; Liu A; Zhang Z; Xu C
Cancer Med; 2023 Jun; 12(11):12581-12592. PubMed ID: 37039264
[TBL] [Abstract][Full Text] [Related]
54. Ly6D facilitates chemoresistance in laryngeal squamous cell carcinoma through miR-509/β-catenin signaling pathway.
Wang J; Sheng N; Li Y; Fan Y; Nan X; Fu R
Am J Cancer Res; 2023; 13(5):2155-2171. PubMed ID: 37293155
[TBL] [Abstract][Full Text] [Related]
55. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH
Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
[TBL] [Abstract][Full Text] [Related]
56. Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells.
Osei-Sarfo K; Gudas LJ
PLoS One; 2019; 14(4):e0215234. PubMed ID: 30978209
[TBL] [Abstract][Full Text] [Related]
57. The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma.
Roh V; Hiou-Feige A; Misetic V; Rivals JP; Sponarova J; Teh MT; Ferreira Lopes S; Truan Z; Mermod M; Monnier Y; Hess J; Tolstonog GV; Simon C
J Pathol; 2020 Jan; 250(1):107-119. PubMed ID: 31465124
[TBL] [Abstract][Full Text] [Related]
58. Association of mRNA Expression Levels of LRP1 and Actin-Binding Proteins with the Development of Laryngeal and Laryngopharyngeal Squamous Cell Carcinoma.
Kakurina GV; Kolegova ЕS; Shashova ЕЕ; Velikaya VV; Startseva ZА; Cheremisina ОV; Kondakova IV; Choinzonov ЕL
Bull Exp Biol Med; 2020 Oct; 169(6):802-805. PubMed ID: 33108559
[TBL] [Abstract][Full Text] [Related]
59. Esophageal squamous cell carcinoma transcriptome reveals the effect of
Nicolau-Neto P; Da Costa NM; de Souza Santos PT; Gonzaga IM; Ferreira MA; Guaraldi S; Moreira MA; Seuánez HN; Brewer L; Bergmann A; Boroni M; Mencalha AL; Kruel CDP; Lima SCS; Esposito D; Simão TA; Pinto LFR
Oncotarget; 2018 Mar; 9(24):16634-16647. PubMed ID: 29682174
[TBL] [Abstract][Full Text] [Related]
60. Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage.
Hui MK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S
World J Surg; 2012 Jan; 36(1):90-7. PubMed ID: 21976009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
